| Year |
Title |
Altmetric |
| 2022
|
Role of chromatin modulator Dpy30 in osteoclast differentiation and function.
Bone.
159.
2022
|
|
| 2022
|
Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer’s Mice.
Frontiers in Immunology.
13.
2022
|
|
| 2021
|
Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.
Molecular Immunology.
137:187-200.
2021
|
|
| 2020
|
Frontline Science: Characterization and regulation of osteoclast precursors following chronic Porphyromonas gingivalis infection.
Journal of Leukocyte Biology.
108:1037-1050.
2020
|
|
| 2020
|
Enhanced dual function of osteoclast precursors following calvarial Porphyromonas gingivalis infection.
Journal of Periodontal Research.
55:410-425.
2020
|
|
| 2020
|
Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.
Influenza and Other Respiratory Viruses.
14:237-243.
2020
|
|
| 2019
|
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost.
npj Vaccines.
4.
2019
|
|
| 2019
|
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018.
Scientific Reports.
9.
2019
|
|
| 2019
|
Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets.
npj Vaccines.
4.
2019
|
|
| 2019
|
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial among Preschool-Aged Children in Urban Bangladesh.
Clinical Infectious Diseases.
69:777-785.
2019
|
|
| 2019
|
The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
Clinical Infectious Diseases.
69:786-794.
2019
|
|
| 2019
|
Update: Influenza activity — United States, september 30, 2018–february 2, 2019
2019
|
|
| 2019
|
Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons.
Eurosurveillance.
24.
2019
|
|
| 2018
|
Influenza activity — United States, September 30–December 1, 2018
2018
|
|
| 2018
|
Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness.
npj Vaccines.
3.
2018
|
|
| 2018
|
Update: Influenza activity — United States and worldwide, May 20–October 13, 2018
2018
|
|
| 2018
|
Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses after Influenza Vaccination in Adults.
Journal of Infectious Diseases.
218:1571-1581.
2018
|
|
| 2018
|
Human infection with avian influenza A(H7N2) virus—Virginia, 2002.
Influenza and Other Respiratory Viruses.
12:529-532.
2018
|
|
| 2018
|
Update: Influenza activity in the united states during the 2017–18 season and composition of the 2018–19 influenza vaccine
2018
|
|
| 2018
|
Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.
PLoS One.
13.
2018
|
|
| 2018
|
Kinetics of Serological Responses in Critically Ill Patients Hospitalized with 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009-2011.
Journal of Infectious Diseases.
217:1078-1088.
2018
|
|
| 2018
|
Update: Influenza activity - United States, October 1, 2017-February 3, 2018
2018
|
|
| 2018
|
Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.
Vaccine.
36:306-312.
2018
|
|
| 2017
|
Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.
Virology.
511:135-141.
2017
|
|
| 2017
|
Update: Influenza activity — United States and worldwide, may 21-september 23, 2017
2017
|
|
| 2017
|
Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
Influenza and Other Respiratory Viruses.
11:394-398.
2017
|
|
| 2017
|
Phenotype and function of myeloidderived suppressor cells induced by Porphyromonas gingivalis infection.
Infection and Immunity.
85.
2017
|
|
| 2017
|
Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
Virology.
508:164-169.
2017
|
|
| 2017
|
CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway.
PLoS One.
12.
2017
|
|
| 2017
|
Update: Influenza activity in the United States during the 2016–17 season and composition of the 2017–18 influenza vaccine
2017
|
|
| 2017
|
Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.
Vaccine.
35:3318-3325.
2017
|
|
| 2017
|
Novel influenza A viruses and pandemic threats
2017
|
|
| 2017
|
Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses.
Journal of Virological Methods.
243:61-67.
2017
|
|
| 2017
|
Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
Influenza and Other Respiratory Viruses.
11:289-297.
2017
|
|
| 2017
|
Increase in human infections with avian influenza a(H7N9) virus during the fifth Epidemic – China, October 2016–February 2017
2017
|
|
| 2017
|
Improving the selection and development of influenza vaccine viruses – Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015.
Vaccine.
35:1104-1109.
2017
|
|
| 2017
|
Update: Influenza activity — United States, October 2, 2016–February 4, 2017
2017
|
|
| 2017
|
A pyrosequencing-based approach to high-throughput identification of influenza A(H3N2) virus clades harboring antigenic drift variants.
Journal of Clinical Microbiology.
55:145-154.
2017
|
|
| 2017
|
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
Influenza and Other Respiratory Viruses.
11:2-14.
2017
|
|
| 2017
|
Cross-reactive antibody responses to novel h5nx influenza viruses following homologous and heterologous prime-boost vaccination with a prepandemic stockpiled a(h5n1) vaccine in humans.
Journal of Infectious Diseases.
216:S555-S559.
2017
|
|
| 2017
|
Effect of priming with seasonal influenza a(h3n2) virus on the prevalence of cross-reactive hemagglutination-inhibition antibodies to swine-origin a(h3n2) variants.
Journal of Infectious Diseases.
216:S539-S547.
2017
|
|
| 2017
|
Mild respiratory illness among young children caused by highly pathogenic avian influenza a (h5n1) virus infection in Dhaka, Bangladesh, 2011.
Journal of Infectious Diseases.
216:S520-S528.
2017
|
|
| 2017
|
Update: Increase in human infections with novel Asian lineage avian influenza a(h7n9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017
2017
|
|
| 2017
|
Update: Influenza activity — United States, October 1–November 25, 2017
2017
|
|
| 2016
|
Update: Influenza activity — United States, October 2-December 17, 2016
2016
|
|
| 2016
|
Seasonal influenza vaccination of children induces humoral and cell-mediated immunity beyond the current season: Cross-reactivity with past and future strains.
Journal of Infectious Diseases.
214:1477-1486.
2016
|
|
| 2016
|
An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice.
Nanomedicine: Nanotechnology, Biology and Medicine.
12:1909-1917.
2016
|
|
| 2016
|
Update: Influenza activity — United States and worldwide, May 22-September 10, 2016
2016
|
|
| 2016
|
Influenza activity - United States, 2015-16 season and composition of the 2016-17 influenza vaccine
2016
|
|
| 2016
|
Selection of antigenically advanced variants of seasonal influenza viruses.
Nature Microbiology.
1.
2016
|
|
| 2016
|
A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.
Virology.
492:197-203.
2016
|
|
| 2016
|
Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
Viral Immunology.
29:259-262.
2016
|
|
| 2016
|
A large proportion of the mexican population remained susceptible to A(H1N1) pdm09 infection one year after the emergence of 2009 influenza pandemic.
PLoS One.
11.
2016
|
|
| 2016
|
Update: Influenza activity — United states, october 4, 2015–february 6, 2016
2016
|
|
| 2016
|
Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.
Vaccine.
34:981-988.
2016
|
|
| 2016
|
A highly immunogenic vaccine against A/H7N9 influenza virus.
Vaccine.
34:744-749.
2016
|
|
| 2016
|
NADPH oxidase 1 is associated with altered host survival and T cell phenotypes after influenza A virus infection in mice.
PLoS One.
11.
2016
|
|
| 2016
|
Randomized controlled trial to compare immunogenicity of standard-dose intramuscular versus intradermal trivalent inactivated influenza vaccine in HIV-infected men who have sex with men in Bangkok, Thailand.
Clinical Infectious Diseases.
62:383-391.
2016
|
|
| 2016
|
Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity.
Vaccine.
34:458-465.
2016
|
|
| 2016
|
Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins.
Scientific Reports.
6.
2016
|
|
| 2015
|
A newly emerged swine-origin influenza a(H3N2) variant dampens host antiviral immunity but induces potent inflammasome activation.
Journal of Infectious Diseases.
212:1923-1929.
2015
|
|
| 2015
|
IL-1R/TLR2 through MyD88 divergently modulates osteoclastogenesis through regulation of nuclear factor of activated T cells c1 (NFATc1) and B lymphocyte-induced maturation protein-1 (Blimp1).
Journal of Biological Chemistry.
290:30163-30174.
2015
|
|
| 2015
|
Update: Influenza activity — United States, October 4–November 28, 2015
2015
|
|
| 2015
|
Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.
Virology.
485:252-262.
2015
|
|
| 2015
|
Increased Dietary Salt Intake Does Not Influence Influenza A Virus-Induced Disease Severity in Mice.
Viral Immunology.
28:532-537.
2015
|
|
| 2015
|
Live animal markets in Minnesota: A potential source for emergence of novel influenza a viruses and interspecies transmission.
Clinical Infectious Diseases.
61:1355-1362.
2015
|
|
| 2015
|
Antibody to influenza virus neuraminidase: An independent correlate of protection.
Journal of Infectious Diseases.
212:1191-1199.
2015
|
|
| 2015
|
Update: Influenza activity — United States and worldwide, may 24–September 5, 2015
2015
|
|
| 2015
|
Strengthening the influenza vaccine virus selection and development process. Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014..
Vaccine.
33:4368-4382.
2015
|
|
| 2015
|
International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE.
Clinical and Vaccine Immunology.
22:957-964.
2015
|
|
| 2015
|
AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes.
Vaccine.
33:3784-3787.
2015
|
|
| 2015
|
Community-acquired pneumonia requiring hospitalization among U.S. adults.
New England Journal of Medicine.
373:415-427.
2015
|
|
| 2015
|
Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.
Virology.
484:305-312.
2015
|
|
| 2015
|
Comparison of traditional intranasal and aerosol inhalation inoculation of mice with influenza A viruses.
Virology.
481:107-112.
2015
|
|
| 2015
|
Environmental conditions affect exhalation of H3N2 seasonal and variant influenza viruses and respiratory droplet transmission in ferrets.
PLoS One.
10.
2015
|
|
| 2015
|
Preexisting immunity, more than aging, influences influenza vaccine responses.
Open Forum Infectious Diseases.
2.
2015
|
|
| 2015
|
Update: Influenza activity-United States, September 28, 2014–February 21, 2015
2015
|
|
| 2015
|
Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets.
Virology.
477:61-71.
2015
|
|
| 2015
|
NLRC5 interacts with RIG-I to induce a robust antiviral response against influenza virus infection.
European Journal of Immunology.
45:758-772.
2015
|
|
| 2015
|
Community-acquired pneumonia requiring hospitalization among U.S. children.
New England Journal of Medicine.
372:835-845.
2015
|
|
| 2015
|
A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 Virus.
Journal of Virology.
89:4655-4667.
2015
|
|
| 2015
|
Emergence of highly pathogenic avian influenza A(H5N1) virus PB1-F2 variants and their virulence in BALB/c mice.
Journal of Virology.
89:5835-5846.
2015
|
|
| 2015
|
Highly pathogenic avian influenza a(H5n1) virus infection among workers at live bird markets, Bangladesh, 2009–2010
2015
|
|
| 2015
|
Influenza activity — United states, 2014–15 season and composition of the 2015–16 influenza vaccine
2015
|
|
| 2014
|
Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness.
mBio.
5.
2014
|
|
| 2014
|
Improved specificity and reduced subtype cross-reactivity for antibody detection by ELISA using globular head domain recombinant hemagglutinin.
Journal of Virological Methods.
209:121-125.
2014
|
|
| 2014
|
Seroincidence of influenza among HIV-infected and HIV-uninfected men during the 2009 H1N1 influenza pandemic, Bangkok, Thailand.
Open Forum Infectious Diseases.
1.
2014
|
|
| 2014
|
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.
Vaccine.
32:6798-6804.
2014
|
|
| 2014
|
Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.
Influenza and Other Respiratory Viruses.
8:628-635.
2014
|
|
| 2014
|
Characterizing wild bird contact and seropositivity to highly pathogenic avian influenza A (H5N1) virus in Alaskan residents.
Influenza and Other Respiratory Viruses.
8:516-523.
2014
|
|
| 2014
|
Influenza vaccination accelerates recovery of ferrets from lymphopenia.
PLoS One.
9.
2014
|
|
| 2014
|
Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients.
Transplantation.
97:846-853.
2014
|
|
| 2014
|
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults.
Vaccine.
32:2251-2259.
2014
|
|
| 2014
|
Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans.
Journal of Infectious Diseases.
209:986-994.
2014
|
|
| 2014
|
Update: Influenza activity - United States, September 29, 2013-February 8, 2014
2014
|
|
| 2014
|
Assessing the impact of public health interventions on the transmission of pandemic H1N1 influenza a virus aboard a Peruvian navy ship.
Influenza and Other Respiratory Viruses.
8:353-359.
2014
|
|
| 2014
|
Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.
Virology.
458-459:114-124.
2014
|
|
| 2014
|
Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines.
Virology.
464-465:156-165.
2014
|
|
| 2014
|
Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
Virology.
454-455:169-175.
2014
|
|
| 2014
|
IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
Clinical and Vaccine Immunology.
21:1054-1060.
2014
|
|
| 2014
|
Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α-actinin-4 for viral replication
2014
|
|
| 2014
|
Influenza virus infectivity and virulence following ocular-only aerosol inoculation of ferrets.
Journal of Virology.
88:9647-9654.
2014
|
|
| 2014
|
Molecular determinants of influenza virus pathogenesis in mice.
Current Topics in Microbiology and Immunology.
385:243-274.
2014
|
|
| 2014
|
Serologic evidence of influenza A(H1N1) pdm09 virus infection in northern sea otters
2014
|
|
| 2013
|
Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.
Virus Research.
178:398-403.
2013
|
|
| 2013
|
Immune responses to infection with H5N1 influenza virus.
Virus Research.
178:44-52.
2013
|
|
| 2013
|
Role of mTOR downstream effector signaling molecules in Francisella tularensis internalization by murine macrophages.
PLoS One.
8.
2013
|
|
| 2013
|
Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
Journal of Virology.
87:13480-13489.
2013
|
|
| 2013
|
Update: Influenza activity - United States, September 29-December 7, 2013
2013
|
|
| 2013
|
Severe acute respiratory infections caused by 2009 pandemic influenza A (H1N1) among American Indians-southwestern United States, May 1-July 21, 2009.
Influenza and Other Respiratory Viruses.
7:1361-1369.
2013
|
|
| 2013
|
Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice.
Virus Research.
177:55-61.
2013
|
|
| 2013
|
Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): Role of the host immune response in pathogenesis.
American Journal of Pathology.
183:1258-1268.
2013
|
|
| 2013
|
Seroprevalence of Antibodies against Highly Pathogenic Avian Influenza A (H5N1) Virus among Poultry Workers in Bangladesh, 2009.
PLoS One.
8.
2013
|
|
| 2013
|
Improving influenza vaccine virus selection: Report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
Influenza and Other Respiratory Viruses.
7:52-53.
2013
|
|
| 2013
|
Considerations regarding appropriate sample size for conducting ferret transmission experiments.
Future Microbiology.
8:961-965.
2013
|
|
| 2013
|
N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.
Journal of Virology.
87:8756-8766.
2013
|
|
| 2013
|
Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice.
Nature.
501:556-559.
2013
|
|
| 2013
|
Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012.
Clinical Infectious Diseases.
57.
2013
|
|
| 2013
|
Comparison of the levels of infectious virus in respirable aerosols exhaled by ferrets infected with influenza viruses exhibiting diverse transmissibility phenotypes.
Journal of Virology.
87:7864-7873.
2013
|
|
| 2013
|
Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice.
Journal of Infectious Diseases.
207:1576-1584.
2013
|
|
| 2013
|
Alexander (Sasha) I. Klimov, PhD, ScD (1943-2013).
Influenza and Other Respiratory Viruses.
7:356-357.
2013
|
|
| 2013
|
Immunological assessment of influenza vaccines and immune correlates of protection.
Expert Review of Vaccines.
12:519-536.
2013
|
|
| 2013
|
Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis.
Journal of Virology.
87:5746-5754.
2013
|
|
| 2013
|
Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness.
PLoS One.
8.
2013
|
|
| 2013
|
Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
Virology.
439:42-46.
2013
|
|
| 2013
|
Kinetics of viral replication and induction of host responses in ferrets differs between ocular and intranasal routes of inoculation.
Virology.
438:56-60.
2013
|
|
| 2013
|
Influenza A(H1N1)pdm09 during air travel.
Travel Medicine and Infectious Disease.
11:110-118.
2013
|
|
| 2013
|
Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice.
Journal of Infectious Diseases.
207:501-510.
2013
|
|
| 2013
|
Transmission studies resume for avian flu.
Science.
339:520-521.
2013
|
|
| 2013
|
Estimating age-specific cumulative incidence for the 2009 influenza pandemic: A meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
Influenza and Other Respiratory Viruses.
7:872-886.
2013
|
|
| 2013
|
Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to porphyromonas gingivalis.
Journal of Leukocyte Biology.
93:21-31.
2013
|
|
| 2013
|
Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza a (H3N2v) virus in ferrets.
Journal of Virology.
87:1261-1263.
2013
|
|
| 2013
|
Seropositivity for influenza A(H1N1) pdm09 virus among frontline health care personnel
2013
|
|
| 2013
|
Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures.
Journal of Virology.
87:2597-2607.
2013
|
|
| 2012
|
Influenza virus titration, antigenic characterization, and serological Mmethods for antibody detection.
Methods in Molecular Biology.
865:25-51.
2012
|
|
| 2012
|
A Mucosal Subunit Vaccine Protects against Lethal Respiratory Infection with Francisella tularensis LVS.
PLoS One.
7.
2012
|
|
| 2012
|
Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 Pandemic.
PLoS One.
7.
2012
|
|
| 2012
|
TLR7 Recognition is dispensable for influenza virus a infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.
Journal of Virology.
86:10988-10998.
2012
|
|
| 2012
|
Protecting adults from influenza: Tis the season to learn from the pandemic.
Journal of Infectious Diseases.
206:803-805.
2012
|
|
| 2012
|
Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection.
Journal of Immunology.
189:2257-2265.
2012
|
|
| 2012
|
Seroprevalence of antibodies to Avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001.
PLoS One.
7.
2012
|
|
| 2012
|
Low pathogenic avian influenza A (H7N2) virus infection in immunocompromised adult, New York, USA, 2003
2012
|
|
| 2012
|
Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.
Journal of Virology.
86:7118-7125.
2012
|
|
| 2012
|
Avian influenza A (H5N1) virus antibodies in poultry cullers, South Korea, 2003-2004
2012
|
|
| 2012
|
Innovations in modeling influenza virus infections in the laboratory.
Trends in Microbiology.
20:275-281.
2012
|
|
| 2012
|
Diagnostic performance of the canine Influenza A Virus subtype H3N8 hemagglutination inhibition assay.
Journal of Veterinary Diagnostic Investigation.
24:499-508.
2012
|
|
| 2012
|
The first cases of 2009 pandemic influenza A (H1N1) virus infection in the United States: A serologic investigation demonstrating early transmission.
Influenza and Other Respiratory Viruses.
6.
2012
|
|
| 2012
|
Antibodies cross-reactive to influenza a (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States
2012
|
|
| 2012
|
The 3′ untranslated regions of influenza genomic sequences are 5′PPP-independent ligands for RIG-i.
PLoS One.
7.
2012
|
|
| 2012
|
Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
PLoS One.
7.
2012
|
|
| 2012
|
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets
2012
|
|
| 2012
|
Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route.
Antimicrobial Agents and Chemotherapy.
56:1616-1618.
2012
|
|
| 2012
|
Local innate immune responses and influenza virus transmission and virulence in ferrets.
Journal of Infectious Diseases.
205:474-485.
2012
|
|
| 2012
|
Pause on avian flu transmission research.
Science.
335:400-401.
2012
|
|
| 2012
|
Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice.
Vaccine.
30:254-264.
2012
|
|
| 2012
|
Reproducibility of serology assays for pandemic influenza H1N1: Collaborative study to evaluate a candidate WHO International Standard.
Vaccine.
30:210-217.
2012
|
|
| 2012
|
Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: Possible involvement in the pathogenesis of human H5N1 virus infection.
Journal of Virology.
86:667-678.
2012
|
|
| 2012
|
Influenza virus respiratory infection and transmission following ocular inoculation in ferrets..
PLoS Pathogens.
8.
2012
|
|
| 2012
|
Use of a human influenza challenge model to assess person-to-person transmission: Proof-of-concept study.
Journal of Infectious Diseases.
205:35-43.
2012
|
|
| 2011
|
Transmission of 2009 pandemic influenza a (H1N1) virus among healthcare personnel-Southern California, 2009.
Infection Control and Hospital Epidemiology.
32:1149-1157.
2011
|
|
| 2011
|
A pre-pandemic outbreak of triple-reassortant swine influenza virus infection among university students, South Dakota, 2008.
Journal of Infectious Diseases.
204:1165-1171.
2011
|
|
| 2011
|
Ocular tropism of influenza a viruses: Identification of H7 subtype-specific host responses in human respiratory and ocular cells.
Journal of Virology.
85:10117-10125.
2011
|
|
| 2011
|
Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus.
PLoS One.
6.
2011
|
|
| 2011
|
Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation.
Infection and Immunity.
79:3792-3800.
2011
|
|
| 2011
|
Serologically confirmed household transmission of 2009 pandemic influenza a (H1N1) virus during the first pandemic wave - New York City, april-may 2009.
Clinical Infectious Diseases.
53:455-462.
2011
|
|
| 2011
|
The ferret as a model organism to study influenza A virus infection.
Disease Models and Mechanisms.
4:575-579.
2011
|
|
| 2011
|
TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-κB.
Journal of Biological Chemistry.
286:24159-24169.
2011
|
|
| 2011
|
Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses.
Immunotechnology : an international journal of immunological engineering.
369:115-124.
2011
|
|
| 2011
|
Influenza a virus nucleoprotein exploits Hsp40 to inhibit PKR activation.
PLoS One.
6.
2011
|
|
| 2011
|
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
Journal of Clinical Microbiology.
49:2210-2215.
2011
|
|
| 2011
|
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.
Expert Review of Anti-infective Therapy.
9:669-683.
2011
|
|
| 2011
|
Influenza virus aerosol exposure and analytical system for ferrets
2011
|
|
| 2011
|
TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.
Journal of Immunology.
186:5772-5783.
2011
|
|
| 2011
|
Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004.
Virology.
413:226-230.
2011
|
|
| 2011
|
Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.
Virology.
413:139-147.
2011
|
|
| 2011
|
Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
Vaccine.
29:2887-2894.
2011
|
|
| 2011
|
Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic.
Journal of Virology.
85:1563-1572.
2011
|
|
| 2011
|
Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection.
Journal of Infectious Diseases.
203:40-48.
2011
|
|
| 2011
|
The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.
Journal of Virology.
85:686-696.
2011
|
|
| 2011
|
The development of vaccine viruses against pandemic A(H1N1) influenza.
Vaccine.
29:1836-1843.
2011
|
|
| 2010
|
A synthetic adjuvant to enhance and expand immune responses to influenza vaccines.
PLoS One.
5.
2010
|
|
| 2010
|
Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus.
Journal of Infectious Diseases.
202:1161-1170.
2010
|
|
| 2010
|
Transforming growth factor-β: Activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis.
PLoS Pathogens.
6.
2010
|
|
| 2010
|
Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.
PLoS One.
5.
2010
|
|
| 2010
|
Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.
PLoS One.
5.
2010
|
|
| 2010
|
Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.
Journal of Virology.
84:7613-7624.
2010
|
|
| 2010
|
Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine.
Vaccine.
28:4928-4936.
2010
|
|
| 2010
|
Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication
2010
|
|
| 2010
|
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.
Virology Journal.
7.
2010
|
|
| 2010
|
Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.
Journal of Virology.
84:4194-4203.
2010
|
|
| 2010
|
Influenza A virus transmission: Contributing factors and clinical implications.
Expert Reviews in Molecular Medicine.
12.
2010
|
|
| 2010
|
Serological surveys for 2009 pandemic influenza A H1N1
2010
|
|
| 2009
|
A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vetnam/1203/2004, in Mice.
Journal of Infectious Diseases.
200:1874-1883.
2009
|
|
| 2009
|
Systems-based candidate genes for human response to influenza infection.
Infection, Genetics and Evolution.
9:1148-1157.
2009
|
|
| 2009
|
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
New England Journal of Medicine.
361:1945-1952.
2009
|
|
| 2009
|
Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
PLoS One.
4.
2009
|
|
| 2009
|
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Influenza and Other Respiratory Viruses.
3:287-295.
2009
|
|
| 2009
|
Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: A public health risk assessment.
Journal of Virology.
83:8131-8140.
2009
|
|
| 2009
|
Requirement of TLR4 and CD14 in dendritic cell activation by Hemagglutinin B from Porphyromonas gingivalis.
Molecular Immunology.
46:2493-2504.
2009
|
|
| 2009
|
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.
Science.
325:484-487.
2009
|
|
| 2009
|
Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004.
Archives of Virology.
154:1249-1261.
2009
|
|
| 2009
|
Ocular infection of mice with influenza A (H7) viruses: A site of primary replication and spread to the respiratory tract.
Journal of Virology.
83:7075-7084.
2009
|
|
| 2009
|
Risk factors associated with subclinical human infection with avian influenza a (H5N1) virus-cambodia, 2006.
Journal of Infectious Diseases.
199:1744-1752.
2009
|
|
| 2009
|
Early control of H5N1 influenza virus replication by the type I interferon response in mice.
Journal of Virology.
83:5825-5834.
2009
|
|
| 2009
|
Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.
Journal of Virology.
83:5726-5734.
2009
|
|
| 2009
|
Past, present, and possible future human infection with influenza virus A subtype H7
2009
|
|
| 2009
|
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
2009
|
|
| 2009
|
Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.
PLoS One.
4.
2009
|
|
| 2009
|
Reply to Zhang.
Journal of Infectious Diseases.
199:1250-1251.
2009
|
|
| 2009
|
Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: Antiviral potential of exogenous alpha interferon to reduce virus shedding.
Journal of Virology.
83:2851-2861.
2009
|
|
| 2009
|
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air
2009
|
|
| 2009
|
Glycogen synthase kinase-3β (GSK3β) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
Molecular Immunology.
46:677-687.
2009
|
|
| 2009
|
Reproducibility of serologic assays for influenza virus A (H5N1)
2009
|
|
| 2009
|
The public health impact of avian influenza viruses.
Poultry Science.
88:872-879.
2009
|
|
| 2008
|
TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensis.
Journal of Leukocyte Biology.
84:1434-1446.
2008
|
|
| 2008
|
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.
New England Journal of Medicine.
359:1631-1633.
2008
|
|
| 2008
|
Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.
Immunological Reviews.
225:68-84.
2008
|
|
| 2008
|
H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice.
PLoS Pathogens.
4.
2008
|
|
| 2008
|
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility
2008
|
|
| 2008
|
Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice.
Journal of Virology.
82:5079-5083.
2008
|
|
| 2008
|
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.
Journal of Infectious Diseases.
197:1185-1188.
2008
|
|
| 2008
|
Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus
2008
|
|
| 2008
|
Influenza A virus (H3N8) in dogs with respiratory disease, Florida
2008
|
|
| 2007
|
Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006.
Journal of Infectious Diseases.
196:1685-1691.
2007
|
|
| 2007
|
New pre-pandemic influenza vaccines: An egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.
Clinical Pharmacology and Therapeutics.
82:665-671.
2007
|
|
| 2007
|
DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza h5N1 virus infection.
Journal of Infectious Diseases.
196:1493-1499.
2007
|
|
| 2007
|
Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells.
Journal of Virology.
81:12439-12449.
2007
|
|
| 2007
|
Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: Enhanced virulence of eurasian H7N7 viruses isolated from humans.
Journal of Virology.
81:11139-11147.
2007
|
|
| 2007
|
The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses.
Journal of Virology.
81:10818-10821.
2007
|
|
| 2007
|
Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice.
Virus Research.
128:159-163.
2007
|
|
| 2007
|
Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
Vaccine.
25:6201-6210.
2007
|
|
| 2007
|
Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.
Clinical and Vaccine Immunology.
14:926-928.
2007
|
|
| 2007
|
Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: An international collaborative study.
Vaccine.
25:4056-4063.
2007
|
|
| 2007
|
NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I.
American Journal of Respiratory Cell and Molecular Biology.
36:263-269.
2007
|
|
| 2007
|
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.
Journal of Virology.
81:2736-2744.
2007
|
|
| 2007
|
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission.
Science.
315:655-659.
2007
|
|
| 2007
|
Growth characterise ties of single gene reassortants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/ 57(H2N2).
Voprosy virusologii.
52:13-16.
2007
|
|
| 2007
|
No evidence of avian influenza A (H5N1) among returning US travelers
2007
|
|
| 2007
|
Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells..
Influenza and Other Respiratory Viruses.
1:95-104.
2007
|
|
| 2006
|
Three Indonesian clusters of H5N1 virus infection in 2005.
New England Journal of Medicine.
355:2186-2194.
2006
|
|
| 2006
|
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Vaccine.
24:6859-6866.
2006
|
|
| 2006
|
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.
Vaccine.
24:6588-6593.
2006
|
|
| 2006
|
Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.
Vaccine.
24:6581-6584.
2006
|
|
| 2006
|
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
Clinical Infectious Diseases.
43:1135-1142.
2006
|
|
| 2006
|
Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model
2006
|
|
| 2006
|
Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system.
Vaccine.
24:5003-5015.
2006
|
|
| 2006
|
Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS.
Infection and Immunity.
74:2809-2816.
2006
|
|
| 2006
|
Response [2].
Science.
311:1552.
2006
|
|
| 2006
|
Response [4].
Science.
311:1241-1242.
2006
|
|
| 2006
|
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
2006
|
|
| 2006
|
Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
Journal of Virology.
80:1959-1964.
2006
|
|
| 2006
|
Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004
2006
|
|
| 2005
|
A distal regulatory region is required for constitutive and IFN-β-induced expression of murine TLR9 gene.
Journal of Immunology.
175:7407-7418.
2005
|
|
| 2005
|
Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.
Journal of Virology.
79:14933-14944.
2005
|
|
| 2005
|
Epidemiology: Transmission of equine influenza virus to dogs.
Science.
310:482-485.
2005
|
|
| 2005
|
Characterization of the reconstructed 1918 Spanish influenza pandemic virus.
Science.
310:77-80.
2005
|
|
| 2005
|
Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis.
Vaccine.
23:4734-4744.
2005
|
|
| 2005
|
Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals.
Journal of Virology.
79:11788-11800.
2005
|
|
| 2005
|
Role of mitogen-activated protein kinases and NF-κB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B.
Infection and Immunity.
73:3990-3998.
2005
|
|
| 2005
|
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: A potential priming strategy.
Journal of Infectious Diseases.
191:1210-1215.
2005
|
|
| 2005
|
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001.
Journal of Virology.
79:4201-4212.
2005
|
|
| 2005
|
Characterization of highly pathogenic H5N1 avian influenza a viruses isolated from South Korea.
Journal of Virology.
79:3692-3702.
2005
|
|
| 2005
|
Evolution of H5N1 avian influenza viruses in Asia
2005
|
|
| 2005
|
Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center..
Clinical Infectious Diseases.
40.
2005
|
|
| 2004
|
Preparing for the next influenza pandemic.
ASM news.
70:412-419.
2004
|
|
| 2004
|
Confronting the avian influenza threat: Vaccine development for a potential pandemic.
Lancet Infectious Diseases.
4:499-509.
2004
|
|
| 2004
|
Innate immunity in aging: Impact on macrophage function.
Aging Cell.
3:161-167.
2004
|
|
| 2004
|
Immunity to influenza: The challenges of protecting an aging population.
Immunologic Research.
29:113-124.
2004
|
|
| 2004
|
Antigenic characteristics of recent avian influenza A H5N1 viruses isolated from humans.
International Congress Series.
1263:109-113.
2004
|
|
| 2004
|
Impaired antigen-induced CD8 + T cell clonal expansion in aging is due to defects in antigen presenting cell function.
Cellular Immunology.
229:86-92.
2004
|
|
| 2004
|
Influenza pandemic vaccines: The imminent challenges from a technical and regulatory perspective.
International Congress Series.
1263:51-54.
2004
|
|
| 2004
|
Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccines.
International Congress Series.
1263:724-727.
2004
|
|
| 2004
|
Role of B7 Costimulatory Molecules in Immune Responses and T-Helper Cell Differentiation in Response to Recombinant HagB from Porphyromonas gingivalis.
Infection and Immunity.
72:637-644.
2004
|
|
| 2004
|
Human illness from avian influenza H7N3, British Columbia
2004
|
|
| 2003
|
Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
Vaccine.
21:4459-4471.
2003
|
|
| 2003
|
Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide.
Journal of Immunology.
171:717-725.
2003
|
|
| 2003
|
Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.
Vaccine.
21:1974-1979.
2003
|
|
| 2003
|
Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A.
Infection and Immunity.
71:2498-2507.
2003
|
|
| 2003
|
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine.
Virology.
308:270-278.
2003
|
|
| 2003
|
Bacterial invasion by a paracellular route: Divide and conquer
2003
|
|
| 2003
|
Current methods for assessing T cell responses to influenza..
Developments in Biologicals.
115:85-93.
2003
|
|
| 2003
|
Evaluation of a genetically modified reassortant H5N1 influenza a virus vaccine candidate generated by plasmid-based reverse genetics.
Virology.
305:192-200.
2003
|
|
| 2003
|
Feasibility of an HA2 domain-based periodontitis vaccine.
Infection and Immunity.
71:562-566.
2003
|
|
| 2003
|
Systemic and cellular immunity..
Developments in Biologicals.
115:107-109.
2003
|
|
| 2002
|
Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.
Infection and Immunity.
70:6779-6787.
2002
|
|
| 2002
|
Cutting edge: Impaired toll-like receptor expression and function in aging.
Journal of Immunology.
169:4697-4701.
2002
|
|
| 2002
|
Microbial/host interactions: Mechanisms involved in host responses to microbial antigens.
Immunologic Research.
26:223-234.
2002
|
|
| 2002
|
Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
Infection and Immunity.
70:3557-3565.
2002
|
|
| 2002
|
Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains.
Infection and Immunity.
70:2512-2518.
2002
|
|
| 2002
|
Pathogenesis of avian influenza A (H5N1) viruses in ferrets.
Journal of Virology.
76:4420-4429.
2002
|
|
| 2002
|
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine.
Vaccine.
20:1019-1029.
2002
|
|
| 2002
|
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice
2002
|
|
| 2002
|
Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China, 1999
2002
|
|
| 2002
|
Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998.
Journal of Infectious Diseases.
185:1005-1010.
2002
|
|
| 2001
|
Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli.
Journal of Immunology.
167:5278-5285.
2001
|
|
| 2001
|
Molecular correlates of influenza A H5N1 virus pathogenesis in mice.
International Congress Series.
1219:595-600.
2001
|
|
| 2001
|
Mucosal vaccination protects mice against influenza A heterosubtypic challenge.
International Congress Series.
1219:985-992.
2001
|
|
| 2001
|
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Cellular Immunology.
211:143-153.
2001
|
|
| 2001
|
Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza a H5N1 virus infection.
Journal of Virology.
75:5141-5150.
2001
|
|
| 2001
|
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
Journal of Virology.
75:4896-4901.
2001
|
|
| 2001
|
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.
Vaccine.
19:1732-1737.
2001
|
|
| 2001
|
A vaccine against dental caries: An overview
2001
|
|
| 2001
|
Vaccines against avian influenza A H9N2 viruses.
International Congress Series.
1219:783-788.
2001
|
|
| 2000
|
Molecular correlates of influenza A H5N1 virus pathogenesis in mice.
Journal of Virology.
74:10807-10810.
2000
|
|
| 2000
|
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents.
Vaccine.
19:308-318.
2000
|
|
| 2000
|
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.
Journal of Virology.
74:6105-6116.
2000
|
|
| 2000
|
A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice.
Vaccine.
18:2177-2187.
2000
|
|
| 2000
|
Cytokine profiles in parotid saliva from HIV-1-infected individuals: Changes associated with opportunistic infections in the oral cavity.
Molecular Oral Microbiology.
15:74-81.
2000
|
|
| 2000
|
Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes.
Infection and Immunity.
68:1441-1449.
2000
|
|
| 2000
|
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong.
Journal of Infectious Diseases.
181:344-348.
2000
|
|
| 2000
|
Avian influenza viruses infecting humans.
Cellular and Molecular Life Sciences.
57:1770-1784.
2000
|
|
| 2000
|
Pathogenesis of and immunity to avian influenza A H5 viruses.
Biomedicine and Pharmacotherapy.
54:178-187.
2000
|
|
| 2000
|
Production of Interleukin-2 in vitro and in vivo in elderly subjects vaccinated with live and inactivated influenza vaccines and their combination.
Voprosy virusologii.
45:25-29.
2000
|
|
| 2000
|
Proliferative activity of lymphocytes of elderly subjects in vitro after separate and combined immunization with live and inactivated influenza vaccines.
Voprosy virusologii.
45:41-45.
2000
|
|
| 1999
|
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts.
Journal of Infectious Diseases.
180:1763-1770.
1999
|
|
| 1999
|
Modified M2 proteins produce heterotypic immunity against influenza A virus.
Vaccine.
17:2237-2244.
1999
|
|
| 1999
|
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.
Journal of Virology.
73:5903-5911.
1999
|
|
| 1999
|
Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997.
Journal of Infectious Diseases.
180:505-508.
1999
|
|
| 1999
|
Detection of antibody to avian influenza a (H5N1) virus in human serum by using a combination of serologic assays.
Journal of Clinical Microbiology.
37:937-943.
1999
|
|
| 1999
|
Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.
Infection and Immunity.
67:4352-4359.
1999
|
|
| 1998
|
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.
Science.
279:393-396.
1998
|
|
| 1998
|
Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalis.
Molecular Oral Microbiology.
13:73-80.
1998
|
|
| 1998
|
Formation of humoral and secretory immunity in elderly subjects immunized with influenza vaccines after different protocols.
Voprosy virusologii.
43:20-24.
1998
|
|
| 1998
|
Relationship between immune response of elderly subjects and number of annual seasonal immunizations with live and inactivated influenza vaccines.
Voprosy virusologii.
43:130-131.
1998
|
|
| 1997
|
Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.
Journal of Infectious Diseases.
175:352-363.
1997
|
|
| 1997
|
Passive Immunization against Dental Plaque Formation in Humans: Effect of a Mouth Rinse Containing Egg Yolk Antibodies (IgY) Specific to Streptococcus mutans.
Caries Research.
31:268-274.
1997
|
|
| 1996
|
Effect of host responses on the pathogenicity of strains of Porphyromonas gingivalis.
Molecular Oral Microbiology.
11:309-318.
1996
|
|
| 1996
|
Host responses induced by co-infection with Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in a murine model.
Molecular Oral Microbiology.
11:274-281.
1996
|
|
| 1995
|
Induction of salivary IgA responses to Streptococcus mutans antigen I/II after intranasal immunization.
Advances in Experimental Medicine and Biology.
371:1153-1156.
1995
|
|
| 1995
|
Oral immunization studies with streptococcus mutans and influenza vaccines in rhesus macaque monkeys.
Advances in Experimental Medicine and Biology.
371:1423-1429.
1995
|
|
| 1995
|
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.
Vaccine.
13:1399-1402.
1995
|
|
| 1994
|
Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation.
Virology.
199:89-97.
1994
|
|
| 1994
|
Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein.
Journal of Virology.
68:6863-6870.
1994
|
|
| 1993
|
Influence of host cell-mediated variation on the international surveillance of influenza a (h3n2) viruses.
Virology.
196:130-137.
1993
|
|
| 1993
|
Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.
Infection and Immunity.
61:1964-1971.
1993
|
|
| 1992
|
Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.
Journal of General Virology.
73:1159-1165.
1992
|
|
| 1992
|
Application of directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens.
Journal of Clinical Microbiology.
30:1072-1075.
1992
|
|
| 1992
|
Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.
Journal of Immunology.
149:1319-1325.
1992
|
|
| 1992
|
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.
Journal of Virology.
66:1129-1138.
1992
|
|
| 1992
|
Extent of γδ T cell involvement in the pneumonia caused by sendai virus.
Cellular Immunology.
143:183-193.
1992
|
|
| 1992
|
Humoral response to Porphyromonas (Bacteroides) gingivalis in rats: Time course and T-cell dependence.
Infection and Immunity.
60:3579-3585.
1992
|
|
| 1992
|
Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses.
Advances in Experimental Medicine and Biology.
327:191-198.
1992
|
|
| 1991
|
A method for generating antigen-specific rat T helper cell clones.
Immunotechnology : an international journal of immunological engineering.
138:77-86.
1991
|
|
| 1991
|
Effect of immune bovine milk on Streptococcus mutans in human dental plaque.
Archives of Oral Biology.
36:41-47.
1991
|
|
| 1990
|
Characterization of rat T helper cell clones specific for Bacteroides gingivalis antigen.
Infection and Immunity.
58:2785-2791.
1990
|
|
| 1990
|
Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.
Journal of Virology.
64:1808-1811.
1990
|
|
| 1989
|
Efficacy of Inactivated Influenza a Virus (H3N2) Vaccines Grown in Mammalian Cells or Embryonated Eggs.
Journal of Infectious Diseases.
160:191-198.
1989
|
|
| 1989
|
Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients.
Virology.
171:275-279.
1989
|
|
| 1989
|
Liposomes as oral adjuvants..
Current Topics in Microbiology and Immunology.
146:51-58.
1989
|
|
| 1988
|
Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.
Virology.
165:446-456.
1988
|
|
| 1987
|
Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutinin.
Cellular Immunology.
109:12-24.
1987
|
|
| 1987
|
Host cell-mediated variation in H3N2 influenza viruses.
Virology.
156:386-395.
1987
|
|
| 1987
|
Novel oral vaccines: the effectiveness of cloned gene products on inducing secretory immune responses..
Advances in Experimental Medicine and Biology.
216 B:1741-1747.
1987
|
|
| 1987
|
Oral vaccines and the secretory immune system.
Clinical and Applied Immunology Reviews.
8:158-159.
1987
|
|
| 1987
|
Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptocococcus mutans.
Infection and Immunity.
55:2341-2347.
1987
|
|
| 1985
|
Cleavage of bovine skin type III collagen by proteolytic enzymes. Relative resistance of the fibrillar form.
Journal of Biological Chemistry.
260:16411-16417.
1985
|
|
| 1985
|
Murine helper T lymphocyte response to influenza virus: recognition of haemagglutinin by subtype-specific and cross-reactive T cell clones.
Vaccine.
3:257-262.
1985
|
|
| 1985
|
Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains.
Journal of Immunology.
134:616-622.
1985
|
|
| 1981
|
In vitro antibody response to influenza virus. II. Specificity of helper T cells recognizing hemagglutinin.
Journal of Immunology.
127:669-672.
1981
|
|
